Elizabeth Bruckheimer

Dr. Elizabeth Bruckheimer received her Ph.D. from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center in Houston Texas. Her professional career spans 15 years in the oncology research, biotech/ pharmaceutical industry, and contract research organizations. In those endeavors, she led cross-functional preclinical and translational drug development programs, laboratory and organizational operations, project management, and business development activities. Prior to joining CPP, Dr. Bruckheimer served as Vice President of Scientific Operations at Champions Oncology leading the development of its TumorGraft platform, and oversaw all scientific operations and project management for Champions’ Translational Oncology Solutions division. Prior to joining Champions Oncology, Dr. Bruckheimer served as Associate Director and Manager at Systems Medicine, LLC. , Senior Scientist at MedImmune, Inc., and Scientist II at Targeted Genetics Corporation where she led the pre-clinical and translational research programs and supported business development opportunities for these organizations. Her expertise and research interests include translational research, oncology drug development, and personalized medicine.